Want to join the conversation?
$BSX said that it received FDA approval for the Precision Montage MRI Spinal Cord Stimulator System. The patients suffering from chronic pain will get full-body access to magnetic resonance imaging procedures, as well as customized therapy through this product.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.